These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 34879282)
1. Parity-induced changes to mammary epithelial cells control NKT cell expansion and mammary oncogenesis. Hanasoge Somasundara AV; Moss MA; Feigman MJ; Chen C; Cyrill SL; Ciccone MF; Trousdell MC; Vollbrecht M; Li S; Kendall J; Beyaz S; Wilkinson JE; Dos Santos CO Cell Rep; 2021 Dec; 37(10):110099. PubMed ID: 34879282 [TBL] [Abstract][Full Text] [Related]
2. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117 [TBL] [Abstract][Full Text] [Related]
3. Pregnancy reprograms the epigenome of mammary epithelial cells and blocks the development of premalignant lesions. Feigman MJ; Moss MA; Chen C; Cyrill SL; Ciccone MF; Trousdell MC; Yang ST; Frey WD; Wilkinson JE; Dos Santos CO Nat Commun; 2020 May; 11(1):2649. PubMed ID: 32461571 [TBL] [Abstract][Full Text] [Related]
4. Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland. Pecha J; Ankrapp D; Jiang C; Tang W; Hoshino I; Bruck K; Wagner KU; Xiao H Oncogene; 2007 Nov; 26(53):7423-31. PubMed ID: 17533366 [TBL] [Abstract][Full Text] [Related]
5. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors. Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967 [TBL] [Abstract][Full Text] [Related]
6. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133 [TBL] [Abstract][Full Text] [Related]
7. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK. Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922 [TBL] [Abstract][Full Text] [Related]
8. Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice. Mastini C; Becker PD; Iezzi M; Curcio C; Musiani P; Forni G; Cavallo F; Guzmán CA Curr Cancer Drug Targets; 2008 May; 8(3):230-42. PubMed ID: 18473736 [TBL] [Abstract][Full Text] [Related]
9. Alveolar progenitor cells develop in mouse mammary glands independent of pregnancy and lactation. Booth BW; Boulanger CA; Smith GH J Cell Physiol; 2007 Sep; 212(3):729-36. PubMed ID: 17443685 [TBL] [Abstract][Full Text] [Related]
10. Immune compartmentalization of T cell subsets in chemically-induced breast cancer. Fahmi T; Esendagli G; Yilmaz G; Kansu E; Guc D Scand J Immunol; 2010 Oct; 72(4):339-48. PubMed ID: 20883319 [TBL] [Abstract][Full Text] [Related]
11. Influence of normal mammary epithelium on breast cancer progression: the protective role of early pregnancy. Martins FC; Botelho MF; Cabrita AM; de Oliveira CF Tumori; 2010; 96(6):999-1003. PubMed ID: 21388065 [TBL] [Abstract][Full Text] [Related]
12. Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis. Mixon M; Kittrell F; Medina D Oncogene; 2000 Nov; 19(46):5237-43. PubMed ID: 11077440 [TBL] [Abstract][Full Text] [Related]
13. Exposure to excess estradiol or leptin during pregnancy increases mammary cancer risk and prevents parity-induced protective genomic changes in rats. de Assis S; Wang M; Jin L; Bouker KB; Hilakivi-Clarke LA Cancer Prev Res (Phila); 2013 Nov; 6(11):1194-211. PubMed ID: 24169961 [TBL] [Abstract][Full Text] [Related]
14. p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis. Yallowitz AR; Alexandrova EM; Talos F; Xu S; Marchenko ND; Moll UM Cell Death Differ; 2014 Apr; 21(4):645-54. PubMed ID: 24440910 [TBL] [Abstract][Full Text] [Related]
15. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
16. Leaving home early: reexamination of the canonical models of tumor progression. Weinberg RA Cancer Cell; 2008 Oct; 14(4):283-4. PubMed ID: 18835030 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-181a/b-1 Is Not Required for Innate γδ NKT Effector Cell Development. Sandrock I; Ziętara N; Łyszkiewicz M; Oberdörfer L; Witzlau K; Krueger A; Prinz I PLoS One; 2015; 10(12):e0145010. PubMed ID: 26673421 [TBL] [Abstract][Full Text] [Related]
18. CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo. Tian G; Courtney AN; Jena B; Heczey A; Liu D; Marinova E; Guo L; Xu X; Torikai H; Mo Q; Dotti G; Cooper LJ; Metelitsa LS J Clin Invest; 2016 Jun; 126(6):2341-55. PubMed ID: 27183388 [TBL] [Abstract][Full Text] [Related]
19. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells. Gerth E; Mattner J Front Immunol; 2019; 10():1449. PubMed ID: 31293596 [TBL] [Abstract][Full Text] [Related]
20. Progesterone promotes immunomodulation and tumor development in the murine mammary gland. Werner LR; Gibson KA; Goodman ML; Helm DE; Walter KR; Holloran SM; Trinca GM; Hastings RC; Yang HH; Hu Y; Wei J; Lei G; Yang XY; Madan R; Molinolo AA; Markiewicz MA; Chalise P; Axelrod ML; Balko JM; Hunter KW; Hartman ZC; Lange CA; Hagan CR J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33958486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]